Heparin and aspirin in stroke

Comment

E Berge et al. Lancet. 2001.

. 2001 Mar 31;357(9261):1044-5.

doi: 10.1016/S0140-6736(05)71619-6.

No abstract available

Comment on

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
[No authors listed] [No authors listed] Lancet. 1997 May 31;349(9065):1569-81. Lancet. 1997. PMID: 9174558 Clinical Trial.
Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.
Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Berge E, et al. Lancet. 2000 Apr 8;355(9211):1205-10. doi: 10.1016/s0140-6736(00)02085-7. Lancet. 2000. PMID: 10770301 Clinical Trial.
Heparin versus aspirin in ischaemic stroke.
Toni D, Argentino C, Fieschi C. Toni D, et al. Lancet. 2000 Aug 5;356(9228):504; author reply 505. doi: 10.1016/S0140-6736(00)02567-8. Lancet. 2000. PMID: 10981908 No abstract available.
Heparin versus aspirin in ischaemic stroke.
Pereira AC, Warburton E. Pereira AC, et al. Lancet. 2000 Aug 5;356(9228):504-5. doi: 10.1016/S0140-6736(05)74171-4. Lancet. 2000. PMID: 10981909 No abstract available.
Heparin and aspirin in stroke.
Restrepo L, Fisch G. Restrepo L, et al. Lancet. 2001 Jan 20;357(9251):233-4. doi: 10.1016/S0140-6736(05)71336-2. Lancet. 2001. PMID: 11213128 No abstract available.